The Concept of CMR
Slides, videos and moreAbout Us
Vincenzo Di Marzo
- 1Scientific Training (1 page)
- 2Current and Past Positions (1 page)
- 3Publications and Book Chapters (1 page)
- 4Awards and Distinctions (1 page)
- 5Professional Associations (1 page)
- 6Additional Information (1 page)
Additional Information
Page:
6 of 6
6 of 6
Editorial Boards
British Journal of Pharmacology, 2004-
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2001-
Journal of Cannabis Therapeutics, 2003-2005
Critical Reviews in Neuroscience, 2003-
Recent Patents in CNS Drug Discovery, 2006-
Dr. Di Marzo coined in 1994 the term “endocannabinoid” for endogenous agonists of cannabinoid receptors.
He also participated in the first studies on the role of the endocannabinoid system in food intake and on the anti-obesity effects of rimonabant in congenitally obese mice (Di Marzo et al., Nature, 2001).
In addition, Dr. Di Marzo put forward the hypothesis of the overactive endocannabinoid system in obesity and hyperglycemia (Di Marzo and Matias, Nat. Neurosci., 2005).
Page:
6 of 6
6 of 6
